DTC

Deep Track Capital Portfolio holdings

AUM $4.38B
1-Year Est. Return 118.22%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+118.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.38B
AUM Growth
+$801M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
73
New
Increased
Reduced
Closed

Top Buys

1
+$124M
2
+$100M
3
+$88.4M
4
ALKS icon
Alkermes
ALKS
+$59.9M
5
SLNO icon
Soleno Therapeutics
SLNO
+$54.8M

Top Sells

1
+$190M
2
+$159M
3
+$155M
4
ETNB
89bio
ETNB
+$138M
5
GH icon
Guardant Health
GH
+$121M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVA
51
Inventiva
IVA
$1.07B
$2.28M 0.05%
+490,000
JANX icon
52
Janux Therapeutics
JANX
$926M
$1.24M 0.03%
+89,589
ANL
53
Adlai Nortye
ANL
$853M
$49.5K ﹤0.01%
+34,852
GHRS icon
54
GH Research
GHRS
$1.22B
– –
-1,250,000
GMAB icon
55
Genmab
GMAB
$16.4B
– –
-481,267
PEPG icon
56
PepGen
PEPG
$111M
– –
-1,200,000
PTGX icon
57
Protagonist Therapeutics
PTGX
$6.46B
– –
-1,715,691
QURE icon
58
uniQure
QURE
$1.13B
– –
-483,092
ACAD icon
59
Acadia Pharmaceuticals
ACAD
$3.82B
– –
-105,085
AKRO
60
DELISTED
Akero Therapeutics
AKRO
– –
-4,000,978
AUTL
61
Autolus Therapeutics
AUTL
$394M
– –
-2,568,613
JBIO
62
Jade Biosciences
JBIO
$1.32B
– –
-2,279,892
AVTX icon
63
Avalo Therapeutics
AVTX
$329M
– –
-144,600
BHVN icon
64
Biohaven
BHVN
$1.44B
– –
0
CDTX
65
DELISTED
Cidara Therapeutics
CDTX
– –
-300,000
ETNB
66
DELISTED
89bio
ETNB
– –
-9,356,171
EXAS
67
DELISTED
Exact Sciences
EXAS
– –
-1,000,000
IMA
68
ImageneBio Inc
IMA
$65.2M
– –
-878,516
OLMA icon
69
Olema Pharmaceuticals
OLMA
$1.33B
– –
-3,470,172
XBI icon
70
State Street SPDR S&P Biotech ETF
XBI
$8.36B
– –
0
XNCR icon
71
Xencor
XNCR
$891M
– –
-549,439
ZURA icon
72
Zura Bio
ZURA
$513M
– –
-259,014
CLYM
73
Climb Bio
CLYM
$454M
– –
-509,789
1 2
3